Submitted by Lorenzo.Piemonte on Tue, 05/31/2016 - 11:57
Insulin was discovered in 1921, first used by an individual with type 1 diabetes in 1922 and then became widely available in the “Western world”. Challenges of access to insulin have been documented and these relate mainly to issues of availability, price and affordability, particularly in low- and middle-income countries.
Submitted by aabolina on Thu, 08/22/2013 - 10:08
Graham Ogle, Angie Middlehurst and Robyn Short-Hobbs
Submitted by aabolina on Thu, 05/23/2013 - 16:09
Professor Bong Yun Cha, Chairman of the Korean Diabetes Association and Dr. Touch Khun, Chief of Diabetology at the Preah Kossamak Hospital in Phnom Penh, Cambodia report on the exciting partnership reflected in the IDF’s Association Twinning Initiative. Learn how people living with diabetes in Cambodia are getting extra help for better care by virtue of the first and more significantly, the second, Cambodia-Korea Twinning Project.
Submitted by olivier.jacqmain on Mon, 04/16/2012 - 14:45
Insulin is a life-sustaining medication, designated an essential drug by the World Health Organization. Although it should be universally available to everyone who requires it for survival, in many countries access to insulin is not secure – resulting in life-threatening complications for large numbers of children and adults with diabetes worldwide. Indeed, most people in most countries of the world who need life-saving insulin cannot obtain it.
Submitted by olivier.jacqmain on Mon, 04/16/2012 - 14:39
The discovery of insulin in 1921 is undoubtedly one of the most significant medical discoveries of the 20th century. Frederick Banting is considered as the main discoverer since he was the one who had the idea of tying a ligature round the pancreatic canals in order to provoke diabetes. when he was still a young surgeon in London, ontario (Canada), he met JJR Macleod of the University of Toronto and suggested experimenting with this procedure in dogs.
Submitted by Lorenzo.Piemonte on Thu, 07/07/2011 - 11:46
The use of HbA1c is becoming mandatory for good-standard diabetes care thanks to scientific evidence generated over the past two decades worldwide. HbA1c as a reflection of chronic hyperglycaemia is also becoming a key indicator increasingly used for the diagnosis of diabetes. however, underserved populations in poor countries have little awareness of or access to this important diagnostic and monitoring tool.
Submitted by admin on Tue, 12/01/2009 - 14:59
Submitted by admin on Tue, 12/01/2009 - 14:54
There are 285 million people living with diabetes worldwide, the number of affected people is predicted to reach 438 million by 2030. Because of the rapid increase in diabetes prevalence, the number of diabetes complications is rising equally quickly. Amputation is one of the most feared of these complications. People with diabetes are at risk for nerve damage and problems with the supply of blood to their feet. Nerve damage results in a reduced ability to feel pain and, as a consequence, injuries often go unnoticed. Moreover, poor blood supply can slow down the process of wound healing.
Submitted by admin on Tue, 12/01/2009 - 14:50
Access to diabetes care in many countries is problematic due to a variety of factors. These can range from the cost of medication to the distance that people with diabetes need to travel to access a trained healthcare provider. Without adequate access to medication and care, people with diabetes face complications and early death. The authors report on an evaluation of the provision of care and supplies for people with diabetes in Vietnam.
Submitted by admin on Thu, 06/18/2009 - 15:42
Four years ago, when Cambodia’s first diabetes surveys were analysed, they surprised everyone: there were twice as many people with diabetes than had been expected – more than 250,000 people. However, the major donors supporting the country’s healthcare sector continue to distribute financial support in unequal shares.